Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2006 (Vol. 26, No. 14)

Development & Production of Antibodies

Looking at the Needs and Challenges and Considering the Range of Possible Alternatives

  • The capacity of large-scale antibody production facilities to meet the worldwide needs of the pharmaceutical industry remains a key issue. Wolfgang Berthold, Ph.D., CTO at Biogen Idec (www.biogen.com), was one of the speakers to address the question at IBC's "Antibody Development and Production" meeting in Carlsbad, CA. This is ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.